Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products

The American Journal of Managed CareFebruary 1996
Volume 2
Issue 2

Related Videos
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.